Patterns of delivery of chemoimmunotherapy to patients with follicular lymphoma in the United States: Results of the National LymphoCare Study
Peter Martin(Northwestern University), Brian K. Link(University of Iowa), Ryan Ziemiecki(RTI Health Solutions), Jonathan W. Friedberg(University of Rochester), Keith Dawson, Christopher R. Flowers(The University of Texas MD Anderson Cancer Center), James R. Cerhan(Mayo Clinic), Michelle Byrtek
Cited by 23
Related Papers
Axicabtagene Ciloleucel CAR T-Cell Therapy in Refractory Large B-Cell Lymphoma
|New England Journal of Medicine|2017|6k
Body-mass index and all-cause mortality: individual-participant-data meta-analysis of 239 prospective studies in four continents
|The Lancet|2016|2.8k
Body-Mass Index and Mortality among 1.46 Million White Adults
|New England Journal of Medicine|2010|2.3k
Targeting BTK with Ibrutinib in Relapsed or Refractory Mantle-Cell Lymphoma
|New England Journal of Medicine|2013|1.7k